Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Reducing myopia progression with red light therapy: Treatment mechanisms and safety levels.

Project description

Understanding red light therapy’s effect on child myopia

Myopia causes distant objects to be focused in front of the retina. The underlying excessive eye elongation increases the risk of eye diseases. Low-level red-light (LRL) therapy is a recent method for reducing myopia progression in children, but reports of retinal damage and reduced vision led to safety concerns. With the support of the Marie Skłodowska-Curie Actions programme, the MyReL project will use a guinea pig myopia model to investigate the effects of LRL and design complementary studies in humans to understand the mechanisms, risks, and long-term safety of LRL treatment, as well as ocular changes associated with it. Ultimately, MyReL aims to provide a hazard-free LRL prototype and recommendations for healthy use of screen devices to control myopia progression in children, thereby reducing the related socioeconomic burden.

Objective

Myopia (shortsightedness) represents a mismatch between the eyes length and its dioptric system (refracting power), which results in distant fixated objects being imaged in front of the retina. The underlying problem is typically excessive eye elongation, multiplying the risk of sight-threatening eye diseases. Faced with rapidly increasing myopia prevalence figures worldwide, and associated huge economic burdens, public health systems need more and improved myopia control in children. A recently described, controversial method for reducing myopia progression in children is low-level red-light therapy (LRL), with clinical trials reporting significant effects with daily, short periods of direct retinal red laser light stimulation. However, a recent report of retinal damage and reduced vision, along with inadequate safety monitoring calls its safety into question. MyReL addresses open questions regarding the underlying mechanism, ocular effects, risks and long-term safety of LRL using an established animal (guinea pig) model of myopia and complimentary studies in humans. The interdisciplinary project will allow detailed evaluation of LRL-induced structural and functional changes in myopic guinea pig eyes. Results from the latter will be used to inform a complimentary human study focused on 3 areas, in which choroidal thickness will serve as a biomarker for therapeutic effects: (1) the intensity-dependent dose-response effects of LRL (limited to established safe intensities), (2) short-term effects of ambient red-light exposure, (3) effects of manipulating the spectrum of digital device screens. Plausible outcomes of these novel studies include a prototype for hazard-free LRL, as well as recommendations on optimal spectral settings for digital devices, both aimed at controlling myopia progression in children. In these ways, MyReL will help to prevent severe eye diseases, with a significant positive impact on health and economic sectors, given EUs aging population.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-GF - HORIZON TMA MSCA Postdoctoral Fellowships - Global Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2023-PF-01

See all projects funded under this call

Coordinator

KUNGLIGA TEKNISKA HOEGSKOLAN
Net EU contribution
€ 282 168,00
Address
BRINELLVAGEN 8
100 44 Stockholm
Sweden
Region
Östra Sverige Stockholm Stockholms län
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Partners (1)